Ranibizumab for Macular Edema Secondary to Central and Branch Retinal Vein Occlusion in Patients Younger Than 50 Years of Age

<div>Graphic representation of the main optical coherence tomography findings at baseline and at 12-month follow-up in central (CRVO (a, b)) and branch retinal vein occlusion (BRVO (c, d)). Legend: SRF: subretinal fluid; ERM: epiretinal membrane; ELM: external limiting membrane; EZ: ellipsoid zone; RPE: retinal pigment epithelium.</div>

BioMed Research International

fig2

Figure 2

Figure 2: Ranibizumab for Macular Edema Secondary to Central and Branch Retinal Vein Occlusion in Patients Younger Than 50 Years of Age 